ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,652,583 | +75.2% | 220,553 | +67.0% | 0.02% | +83.3% |
| Q2 2023 | $11,788,408 | -21.0% | 132,083 | -5.1% | 0.01% | -25.0% |
| Q1 2023 | $14,926,740 | +4.7% | 139,216 | +19.3% | 0.02% | 0.0% |
| Q4 2022 | $14,253,060 | +50.3% | 116,704 | +27.1% | 0.02% | +45.5% |
| Q3 2022 | $9,480,000 | +2.2% | 91,810 | -8.0% | 0.01% | 0.0% |
| Q2 2022 | $9,276,000 | -48.0% | 99,782 | -34.3% | 0.01% | -35.3% |
| Q1 2022 | $17,834,000 | -14.3% | 151,959 | -1.7% | 0.02% | 0.0% |
| Q4 2021 | $20,801,000 | +297.6% | 154,620 | +371.0% | 0.02% | +240.0% |
| Q3 2021 | $5,232,000 | +181.7% | 32,827 | +132.5% | 0.01% | +150.0% |
| Q2 2021 | $1,857,000 | -11.9% | 14,117 | -13.7% | 0.00% | 0.0% |
| Q1 2021 | $2,109,000 | -44.1% | 16,367 | -27.6% | 0.00% | -33.3% |
| Q4 2020 | $3,771,000 | +49.3% | 22,608 | +38.1% | 0.00% | 0.0% |
| Q3 2020 | $2,525,000 | -15.2% | 16,365 | -18.8% | 0.00% | -25.0% |
| Q2 2020 | $2,979,000 | +32.3% | 20,146 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $2,252,000 | +619.5% | 19,999 | +789.2% | 0.00% | – |
| Q4 2019 | $313,000 | -78.1% | 2,249 | -84.8% | 0.00% | -100.0% |
| Q3 2019 | $1,428,000 | -27.0% | 14,822 | -12.7% | 0.00% | 0.0% |
| Q2 2019 | $1,956,000 | -93.6% | 16,985 | -93.4% | 0.00% | -94.9% |
| Q1 2019 | $30,387,000 | +950.4% | 258,177 | +459.1% | 0.04% | +875.0% |
| Q4 2018 | $2,893,000 | +1.3% | 46,181 | +14.6% | 0.00% | +33.3% |
| Q3 2018 | $2,856,000 | +115.5% | 40,300 | +102.3% | 0.00% | +50.0% |
| Q2 2018 | $1,325,000 | +266.0% | 19,923 | +259.5% | 0.00% | – |
| Q1 2018 | $362,000 | – | 5,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |